India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market Size, Competitive Landscape and Market Forecast - 2029

SKU: DMPH2861 | Last Updated On: Jun 23 2022 | Available Formats

> India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market Expected to reach a high CAGR during the forecast period 2022-2029: DataM Intelligence

India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market is segmented By Medication Type (HCV Protease Inhibitors, HCV Polymerase Inhibitors (Sofosbuvir (Sovaldi)), HCV NS5A Inhibitors, Interferons and ribavirin (Interferon alfa-2b (Intron-A), Peginterferon alfa-2b (PEG-Intron, Sylatron), Pegylated interferon alfa-2a (Pegasys), Ribavirin (Rebetol, Virazole, Copegus, Moderiba, Ribasphere)), Combination Products (Ledipasvir/sofosbuvir (Harvoni), Ombitasvir/paritaprevir/ritonavir & dasabuvir (Viekira Pak), Ombitasvir/paritaprevir/ritonavir (Technivie), Elbasvir/grazoprevir (Zepatier), Glecaprevir/pibrentasvir (Mavyret), Sofosbuvir/velpatasvir (Epclusa), Sofosbuvir/velpatasvir/voxilaprevir (Vosevi)), Thrombopoietin-Receptor Agonists (Eltrombopag (Promacta)), Others), By Disease Type (Acute Hepatitis C, Chronic Hepatitis C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), and By Region – Share, Size, Outlook, and Opportunity Analysis, 2022-2029


Market Overview

The India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market is expected to grow at a CAGR during the forecasting period (2022-2029).

Hepatitis C Virus (HCV) is an infection that affects the liver which may lead to serious consequences if not taken care of. It spreads through infected blood transfusions and poorly sterilized medical equipment.

The number of patients has increased significantly because its symptoms take time to be recognized before the patient progresses towards clinically visible liver damage which worsens the situation since it may lead to liver damage or even failure.

There was no proper therapy for HCV before 2010 but the coming of therapies like Sovaldi and Harvoni by Gilead and Viekira Pak by AbbVie has improved the scenario. Also, the steps taken like proper blood screening is helping in identifying the patients.

Some of the major players include: AbbVie Inc., Gilead Sciences, Inc., Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc, Merck, F. Hoffmann-La Roche Ltd, among other

Trending Topics

Hepatitis Diagnostic Testing Market

Hepatitis A Vaccine Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!